Publication | Closed Access

Pinocembrin relieves lipopolysaccharide and bleomycin induced lung inflammation via inhibiting TLR4-NF-κB-NLRP3 inflammasome signaling pathway

InflammationInduced Lung InflammationAnti-inflammatoryInflammatory Lung DiseaseLung InflammationMedicineImmunologyChronic InflammationPulmonary PharmacologyPulmonary FibrosisImmune FunctionPharmacologyInflammatory DiseaseCell SignalingTlr4-nf-κb-nlrp3 Inflammasome